Pulished Date August, 2019
ID: 6557
Share on
Share on

Acne Medication Market Analysis - By Type (OTC, Prescription Drugs), By Route of Administration (Oral, Topical), By Drug Class (Antibiotics, Anti-inflammatory Drugs, Anti-Microbial, Combination Drugs, Hormonal Agents, Oral Retinoids, Topical Retinoids) & By Region – Size, Share, Trends, Growth, Global Forecast | 2019 - 2024

Pulished: August, 2019
ID: 6557
Pages: 175

Global Acne Medication Market Size & Growth (2019 - 2024)

The global market for Acne Medication had decent growth in the past few years and expected to continue the same trend during the forecast period.

Acne is a skin disease that is characterized by pimples, oily skin, and blackheads. It can be caused due to dead skin cells, clogged hair follicles, and oil from the skin. It generally affects the region with a considerably higher number of sweat glands like the upper part of the chest, back and face.

Key Market Growth Drivers

An unhealthy urban lifestyle and the growing number of cases of acne are the major factors driving the market growth. As people are becoming conscious about their looks, the market is expected to propel during the forecast period.

Major Challenges

However, side effects associated with the use of acne medication and alternative treatments available in the market are hampering the market growth.

Details of the report:

Report Metric

Details

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Route of Administration, Drug  Class, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

 

This research report on the Global Acne Medication Market has been segmented and sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.

Acne Medication Market Analysis – By Type:

  • OTC drugs
  • Prescription drugs

Acne Medication Market Analysis – By Route of Administration:

  • Topical
  • Oral

Acne Medication Market Analysis – By Drug Class:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Anti-Microbial
  • Combination Drugs
  • Hormonal Agents
  • Oral Retinoid
  • Topical Retinoid

On the basis of drug class, the Anti-inflammatory segment holds a major share of the market revenue.

Acne Medication Market Analysis – By Region:

  • North America
  • Europe
  • APAC
  • Latin America
  • MEA

Regionally, the Acne Medication market was dominated by Europe closely followed by North America. Asia Pacific is expected to grow at a high CAGR.

Top companies in the market

Some of the major companies dominating the market, by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 OTC drugs

                                5.1.3 Prescription drugs

                                5.1.4  Y-o-Y Growth Analysis, By type     

                                5.1.5  Market Attractiveness Analysis, By type   

                                5.1.6 Market Share Analysis, By type      

                5.2 Route of administration                        

                                5.2.1 Introduction           

                                5.2.2 Topical      

                                5.2.3 Oral            

                                5.2.4 Y-o-Y Growth Analysis, By route of administration

                                5.2.5 Market Attractiveness Analysis, By route of administration              

                                5.2.6 Market Share Analysis, By route of administration

                5.3 Drug class                    

                                5.3.1 Introduction           

                                5.3.2 Antibiotics               

                                5.3.3 Anti-inflammatory drugs   

                                5.3.4 Anti-microbials      

                                5.3.5 Combination drugs              

                                5.3.6 Hormonal agents  

                                5.3.7 Oral retinoids         

                                5.3.8 Topical retinoids   

                                5.3.7 Y-o-Y Growth Analysis, By drug class            

                                5.3.8  Market Attractiveness Analysis, By drug class         

                                5.3.9  Market Share Analysis, By drug class          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By type

                                                6.1.3.3 By route of administration

                                                6.1.3.4 By drug class

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By type

                                                6.1.4.3 By route of administration

                                                6.1.4.4 By drug class

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By type

                                                6.1.5.3 By route of administration

                                                6.1.5.4 By drug class

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline plc                

                8.3 Novartis AG                

                8.4 Merck & Co. Inc                        

                8.5 Amgen, Inc.                

                8.6 Abbott Laboratories                               

                8.7 Eli Lilly and Company                              

                8.8 Daiichi Sankyo Company, Ltd                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of route, by Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Global Acne Medication Market By Region, From 2019-2024 ( USD Billion )
  2. Global Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  3. Global Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  4. Global Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  5. Global Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  6. Global Topical Market By Region, From 2019-2024 ( USD Billion )
  7. Global Oral Market By Region, From 2019-2024 ( USD Billion )
  8. Global Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  9. Global Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  10. Global Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  11. Global Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  12. Global Combination Market By Region, From 2019-2024 ( USD Billion )
  13. Global Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  14. Global Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  15. Global Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  16. North America Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  17. North America Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  18. North America Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  19. North America Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  20. North America Topical Market By Region, From 2019-2024 ( USD Billion )
  21. North America Oral Market By Region, From 2019-2024 ( USD Billion )
  22. North America Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  23. North America Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  24. North America Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  25. North America Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  26. North America Combination Market By Region, From 2019-2024 ( USD Billion )
  27. North America Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  28. North America Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  29. North America Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  30. United States Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  31. United States Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  32. United States Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  33. Canada Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  34. Canada Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  35. Canada Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  36. Europe Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  37. Europe Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  38. Europe Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  39. Europe Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  40. Europe Topical Market By Region, From 2019-2024 ( USD Billion )
  41. Europe Oral Market By Region, From 2019-2024 ( USD Billion )
  42. Europe Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  43. Europe Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  44. Europe Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  45. Europe Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  46. Europe Combination Market By Region, From 2019-2024 ( USD Billion )
  47. Europe Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  48. Europe Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  49. Europe Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  50. U.K. Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  51. U.K. Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  52. U.K. Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  53. Germany Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  54. Germany Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  55. Germany Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  56. France Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  57. France Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  58. France Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  59. Italy Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  60. Italy Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  61. Italy Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  62. Spain Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  63. Spain Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  64. Spain Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  65. Asia Pacific Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  66. Asia Pacific Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  67. Asia Pacific Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  68. Asia Pacific Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  69. Asia Pacific Topical Market By Region, From 2019-2024 ( USD Billion )
  70. Asia Pacific Oral Market By Region, From 2019-2024 ( USD Billion )
  71. Asia Pacific Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  72. Asia Pacific Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  73. Asia Pacific Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  74. Asia Pacific Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  75. Asia Pacific Combination Market By Region, From 2019-2024 ( USD Billion )
  76. Asia Pacific Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  77. Asia Pacific Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  78. Asia Pacific Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  79. Japan Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  80. Japan Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  81. Japan Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  82. China Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  83. China Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  84. China Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  85. India Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  86. India Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  87. India Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  88. Australia Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  89. Australia Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  90. Australia Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  91. South Korea Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  92. South Korea Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  93. South Korea Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  94. Latin America Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  95. Latin America Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  96. Latin America Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  97. Latin America Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  98. Latin America Topical Market By Region, From 2019-2024 ( USD Billion )
  99. Latin America Oral Market By Region, From 2019-2024 ( USD Billion )
  100. Latin America Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  101. Latin America Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  102. Latin America Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  103. Latin America Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  104. Latin America Combination Market By Region, From 2019-2024 ( USD Billion )
  105. Latin America Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  106. Latin America Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  107. Latin America Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  108. Brazil Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  109. Brazil Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  110. Brazil Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  111. Argentina Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  112. Argentina Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  113. Argentina Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  114. Mexico Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  115. Mexico Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  116. Mexico Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  117. Rest of Latin America Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  118. Rest of Latin America Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  119. Rest of Latin America Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  120. Middle East and Africa Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  121. Middle East and Africa Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  122. Middle East and Africa Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  123. Middle East and Africa Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  124. Middle East and Africa Topical Market By Region, From 2019-2024 ( USD Billion )
  125. Middle East and Africa Oral Market By Region, From 2019-2024 ( USD Billion )
  126. Middle East and Africa Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  127. Middle East and Africa Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  128. Middle East and Africa Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  129. Middle East and Africa Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  130. Middle East and Africa Combination Market By Region, From 2019-2024 ( USD Billion )
  131. Middle East and Africa Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  132. Middle East and Africa Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  133. Middle East and Africa Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  134. Middle East Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  135. Middle East Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  136. Middle East Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  137. Africa Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  138. Africa Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  139. Africa Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample